Crossmark

Selective modulation of the cannabinoid type 1 (CB<sub>1</sub>) receptor as an emerging platform for the treatment of neuropathic pain

Crossref DOI link: https://doi.org/10.1039/C8MD00595H

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Banister, Samuel D.

Krishna Kumar, Kaavya

Kumar, Vineet

Kobilka, Brian K.

Malhotra, Sanjay V. https://orcid.org/0000-0003-4056-5033
License Information

Accepted Manuscript valid from 2020-03-18
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: Sanjay V. Malhotra (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 4 December 2018; Accepted 12 March 2019; Accepted Manuscript published 18 March 2019; Advance Article published 10 April 2019; Version of Record published 22 May 2019